MRK · Merck & Co., Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-30 | Seidman Christine E |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. |
Phantom Stock
|
63 |
| 2026-06-30 | Karsanbhai Surendralal Lanca |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. |
Phantom Stock
|
126 |
| 2026-06-30 | Coe Mary Ellen |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. |
Phantom Stock
|
233 |
| 2026-05-29 | RUSSO PATRICIA F |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | Warden Kathy J |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | Craig Pamela J. |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | BAKER DOUGLAS M JR |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | THULIN INGE G |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | Coe Mary Ellen |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | Rothman Paul |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | LAVIZZO-MOUREY RISA J |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | Karsanbhai Surendralal Lanca |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | GLOCER THOMAS H |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | Seidman Christine E |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-29 | Mayo Stephen |
Director |
Award↑
Filing footnotes — Phantom Stock (Direct)
1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. |
Phantom Stock
|
1,853 |
| 2026-05-05 | Zachary Jennifer |
EVP, General Counsel |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
12,064 |
| 2026-05-05 | DeLuca Richard R. |
EVP&Pres, Merck Animal Heallth |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
11,931 |
| 2026-05-05 | Guindo Chirfi |
Chief Marketing Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
6,628 |
| 2026-05-05 | Foard Brian |
EVP, Specialty, Pharma, & ID |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
31,044 |
| 2026-05-05 | Li Dean Y |
Executive VP & President, MRL |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
58,207 |
| 2026-05-05 | Foard Brian |
EVP, Specialty, Pharma, & ID |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
35,351 |
| 2026-05-05 | Guindo Chirfi |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
19,402 |
| 2026-05-05 | Foard Brian |
EVP, Specialty, Pharma, & ID |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
10,605 |
| 2026-05-05 | Davis Robert M |
Director, Chairman, CEO & President |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
47,724 |
| 2026-05-05 | Williams David Michael |
EVP,Chief Info&Digital Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
4,640 |
| 2026-05-05 | Zachary Jennifer |
EVP, General Counsel |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
35,312 |
| 2026-05-05 | Larson Betty D |
EVP, Chief HR Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
23,283 |
| 2026-05-05 | Smart Dalton E. III |
SVP Fin. - Global Controller |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
2,298 |
| 2026-05-05 | Oosthuizen Johannes Jacobus |
President, U.S. Market |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
31,044 |
| 2026-05-05 | Litchfield Caroline |
EVP & CFO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
46,566 |
| 2026-05-05 | Maraldo David R. |
EVP & Pres. MMD |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
7,424 |
| 2026-05-05 | Oosthuizen Johannes Jacobus |
President, U.S. Market |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
10,605 |
| 2026-05-05 | DeLuca Richard R. |
EVP&Pres, Merck Animal Heallth |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
34,924 |
| 2026-05-05 | Maraldo David R. |
EVP & Pres. MMD |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
21,731 |
| 2026-05-05 | Davis Robert M |
Director, Chairman, CEO & President |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
139,697 |
| 2026-05-05 | Larson Betty D |
EVP, Chief HR Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
7,954 |
| 2026-05-05 | Li Dean Y |
Executive VP & President, MRL |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
19,885 |
| 2026-05-05 | Litchfield Caroline |
EVP & CFO |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Restricted Stock Unit
|
15,908 |
| 2026-05-05 | Smart Dalton E. III |
SVP Fin. - Global Controller |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
5,045 |
| 2026-05-05 | Williams David Michael |
EVP,Chief Info&Digital Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
Stock Option (Right to Buy)
|
13,582 |
| 2026-05-02 | Maraldo David R. |
EVP & Pres. MMD |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025, and 5/2/2026. |
Restricted Stock Unit
|
552 |
| 2026-05-02 | Smart Dalton E. III |
SVP Fin. - Global Controller |
Tax↓
|
Common Stock
|
132 |
| 2026-05-02 | Maraldo David R. |
EVP & Pres. MMD |
Convert↑
|
Common Stock
|
552 |
| 2026-05-02 | Maraldo David R. |
EVP & Pres. MMD |
Tax↓
|
Common Stock
|
159 |
| 2026-05-02 | Smart Dalton E. III |
SVP Fin. - Global Controller |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025, and 5/2/2026. |
Restricted Stock Unit
|
383 |
| 2026-05-02 | Smart Dalton E. III |
SVP Fin. - Global Controller |
Convert↑
|
Common Stock
|
383 |
| 2026-04-30 | Smart Dalton E. III |
SVP Fin. - Global Controller |
Tax↓
|
Common Stock
|
159 |
| 2026-04-30 | Larson Betty D |
EVP, Chief HR Officer |
Convert↑
|
Common Stock
|
11,350 |
| 2026-04-30 | Smart Dalton E. III |
SVP Fin. - Global Controller |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. |
Restricted Stock Unit
|
464 |
| 2026-04-30 | Smart Dalton E. III |
SVP Fin. - Global Controller |
Convert↑
|
Common Stock
|
464 |